Company Filing History:
Years Active: 2012-2014
Title: Bauke Ylstra: Innovator in Cancer Research
Introduction
Bauke Ylstra is a prominent inventor based in San Francisco, CA, who has made significant contributions to the field of cancer research. With a focus on genetic markers, his work aims to enhance the detection and understanding of cancer predisposition.
Latest Patents
Ylstra holds 2 patents, with his latest invention centered around detecting CYP24 expression levels as a marker for predisposition to cancer. This invention reveals that an amplification of the CYP24 gene or an increase in CYP24 activity can indicate the presence or progression of cancer, such as breast cancer. The methods developed involve providing a biological sample from an animal, detecting the level of CYP24 within that sample, and comparing it to a control sample from normal, cancer-free tissue. An increased level of CYP24 in the biological sample suggests the presence of cancer in the animal.
Career Highlights
Bauke Ylstra is affiliated with the University of California, where he continues to advance his research in cancer detection and genetic markers. His innovative approaches have the potential to significantly impact cancer diagnostics and treatment strategies.
Collaborations
Ylstra has collaborated with notable colleagues, including Donna G Albertson and Daniel Pinkel, contributing to a rich environment of research and innovation.
Conclusion
Bauke Ylstra's work exemplifies the intersection of innovation and healthcare, particularly in the realm of cancer research. His contributions are paving the way for improved detection methods that could ultimately save lives.